Literature DB >> 28066056

MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.

Andrew Arnold1.   

Abstract

Primary hyperparathyroidism is primarily due to a solitary parathyroid adenoma but multi-gland disease, parathyroid carcinoma, and ectopic parathyroid hormone production can occur. Although primary hyperparathyroidism mostly presents sporadically, strong familial predispositions also exist. Much is known about heritable genetic mutations responsible for these syndromes, including multiple endocrine neoplasia types 1 and 2A, hyperparathyroidism-jaw tumor syndrome, and familial hypocalciuric hypercalcemia. Acquired mutations in common sporadic hyperparathyroidism have also been discovered. Here we focus on the most common and well-established genetic drivers: 1) involvement of the oncogene cyclin D1 in human neoplasia was first established in parathyroid adenomas, followed by recognition of its importance in other tumor types including breast cancer and B-lymphoid malignancy; and 2) somatic mutation of the MEN1 gene, first identified as the source of pathogenic germline mutations in patients with familial endocrinopathies, is found in a substantial fraction of non-familial parathyroid adenomas.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28066056      PMCID: PMC5216514     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  38 in total

Review 1.  In search of tumor suppressing functions of menin.

Authors:  Yuqing Yang; Xianxin Hua
Journal:  Mol Cell Endocrinol       Date:  2007-01-11       Impact factor: 4.102

Review 2.  Cyclin D1 in breast cancer pathogenesis.

Authors:  Andrew Arnold; Alexandros Papanikolaou
Journal:  J Clin Oncol       Date:  2005-06-20       Impact factor: 44.544

3.  Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Authors:  Akihiko Yokoyama; Michael L Cleary
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

Review 4.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

5.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

6.  Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.

Authors:  C Byström; C Larsson; C Blomberg; K Sandelin; U Falkmer; B Skogseid; K Oberg; S Werner; M Nordenskjöld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.

Authors:  Ziqiang Yuan; Carmen Sánchez Claros; Masako Suzuki; Elaine C Maggi; Justin D Kaner; Noah Kinstlinger; Jolanta Gorecka; Thomas J Quinn; Rula Geha; Amanda Corn; Jessica Pastoriza; Qiang Jing; Asha Adem; Hao Wu; Girum Alemu; Yi-Chieh Du; Deyou Zheng; John M Greally; Steven K Libutti
Journal:  Oncotarget       Date:  2016-03-15

8.  MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.

Authors:  Gerard V Walls; Manuel C Lemos; Mahsa Javid; Miriam Bazan-Peregrino; Jeshmi Jeyabalan; Anita A C Reed; Brian Harding; Damian J Tyler; Daniel J Stuckey; Sian Piret; Paul T Christie; Olaf Ansorge; Kieran Clarke; Len Seymour; Rajesh V Thakker
Journal:  Cancer Res       Date:  2012-08-21       Impact factor: 12.701

9.  Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia.

Authors:  Brian Harding; Manuel C Lemos; Anita A C Reed; Gerard V Walls; Jeshmi Jeyabalan; Michael R Bowl; Hilda Tateossian; Nicky Sullivan; Tertius Hough; William D Fraser; Olaf Ansorge; Michael T Cheeseman; Rajesh V Thakker
Journal:  Endocr Relat Cancer       Date:  2009-07-20       Impact factor: 5.678

Review 10.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

View more
  3 in total

1.  Proteomics Analysis of Tissue Samples Reveals Changes in Mitochondrial Protein Levels in Parathyroid Hyperplasia over Adenoma.

Authors:  Gurler Akpinar; Murat Kasap; Nuh Zafer Canturk; Mehin Zulfigarova; Eylül Ece Islek; Sertac Ata Guler; Turgay Simsek; Zeynep Canturk
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

2.  Whole exome sequencing in familial isolated primary hyperparathyroidism.

Authors:  F Cetani; E Pardi; P Aretini; F Saponaro; S Borsari; L Mazoni; M Apicella; P Civita; M La Ferla; M A Caligo; F Lessi; C M Mazzanti; L Torregossa; A Oppo; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-09-05       Impact factor: 4.256

3.  Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.

Authors:  Ya Hu; Xiang Zhang; Ou Wang; Ming Cui; Xiaobin Li; Mengyi Wang; Surong Hua; Quan Liao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.